Obesity poses an increased risk of developing
metabolic syndrome and closely associated
nonalcoholic fatty liver disease, including
liver cancer. Satiety
hormone leptin-deficient (ob/ob) mice, considered paradigmatic of nutritional
obesity, develop hepatic steatosis but are less prone to developing liver
tumors. Sustained activation of
peroxisome proliferator-activated receptor α (PPARα) in ob/ob mouse liver increases
fatty acid oxidation (FAO), which contributes to attenuation of
obesity but enhances
liver cancer risk. To further evaluate the role of PPARα-regulated hepatic FAO and energy burning in the progression of
fatty liver disease, we generated PPARα-deficient ob/ob (PPARα(Δ)ob/ob) mice. These mice become strikingly more obese compared to ob/ob littermates, with increased white and brown adipose tissue content and severe hepatic steatosis. Hepatic steatosis becomes more severe in fasted PPARα(Δ)ob/ob mice as they fail to up-regulate FAO systems. PPARα(Δ)ob/ob mice also do not respond to peroxisome proliferative and mitogenic effects of PPARα agonist
Wy-14,643. Although PPARα(Δ)ob/ob mice are severely obese, there was no significant increase in liver
tumor incidence, even when maintained on a diet containing
Wy-14,643. We conclude that sustained PPARα activation-related increase in FAO in fatty livers of obese ob/ob mice increases
liver cancer risk, whereas deletion of PPARα in ob/ob mice aggravates
obesity and hepatic steatosis. However, it does not lead to liver
tumor development because of reduction in FAO and energy burning.